Jason Butch's most recent trade in Agile Therapeutics Inc was a trade of 6,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Nov. 9, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Agile Therapeutics Inc | Jason Butch | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2022 | 6,000 | 6,000 | - | - | Employee Stock Option (Right to Buy) | |
Agile Therapeutics Inc | Jason Butch | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 40,000 | 40,000 | - | - | Employee Stock Option (Right to Buy) | |
Agile Therapeutics Inc | Jason Butch | Principal Accounting Officer | Purchase of securities on an exchange or from another person at price $ 2.01 per share. | 26 Mar 2021 | 8,642 | 18,642 (0%) | 0% | 2.0 | 17,370 | Common Stock |
Agile Therapeutics Inc | Jason Butch | Principal Accounting Officer | Purchase of securities on an exchange or from another person at price $ 1.99 per share. | 26 Mar 2021 | 1,358 | 20,000 (0%) | 0% | 2.0 | 2,702 | Common Stock |
Agile Therapeutics Inc | Jason Butch | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 25,000 | 25,000 | - | - | Employee Stock Option (Right to Buy) |